Navigation Links
Cardiome And Astellas Announce Positive Results From ACT 2 Trial

traded on the Toronto Stock Exchange (COM) and the NASDAQ National Market (CRME).

About Astellas Pharma US, Inc.

Astellas Pharma US, Inc., located in Deerfield, Illinois, is a US affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The organization is committed to becoming a global pharmaceutical company by combining outstanding R&D and marketing capabilities and continuing to grow in the world pharmaceutical market. For more information about Astellas Pharma US, Inc., please visit our website at www.astellas.com/us.

Forward-Looking Statement Disclaimer

Certain statements in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 or forward-looking information under applicable Canadian securities legislation that may not be based on historical fact, including without limitation statements containing the words "believe", "may", "plan", "will", "estimate", "continue", "anticipate", "intend", "expect" and similar expressions. Such forward-looking statements or information involve known and unknown risks, uncertainties and other factors that may cause our actual results, events or developments, or industry results, to be materially different from any future results, events or developments expressed or implied by such forward-looking statements or information. Such factors include, among others, our stage of development, lack of product revenues, additional capital requirements, risk associated with the completion of clinical trials and obtaining regulatory approval to market our products, the ability to protect our intellectual property, dependence on collaborative partners and the prospects for negotiating additional corporate collaborations or l
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cardiome And Astellas Announce Positive Results From ACT Trial
(Date:4/28/2015)... , April 28, 2015 ... Berlin and the Charité creates ... as a central research location   ... technical and medical information products and services, has announced ... the Humboldt University (Humboldt-Universität), the Free University of ...
(Date:4/28/2015)... WILMINGTON, N.C. , April 28, 2015 ... of the Year (CRoY) winners in the UK, joining the ... earned the Gold Pharma in the CTA category and ... Both Chiltern Source professionals are working with Novartis. ... this recognition as top performers in the industry," commented ...
(Date:4/28/2015)...   GenSpera, Inc. (OTCQB: GNSZ) announced ... has issued U.S. Patent No. 8,957,016. This patent ... for the company,s prodrugs designed to be activated ... GenSpera is developing a series of prodrugs that ... from the poisonous plant, Thapsia garganica . The ...
Breaking Medicine Technology:Elsevier and the Friedrich-Althoff Consortium Collaborate to Create "Archive of Berlin" as a Basis for a Common Research Infrastructure 2Elsevier and the Friedrich-Althoff Consortium Collaborate to Create "Archive of Berlin" as a Basis for a Common Research Infrastructure 3Chiltern expands PharmaTimes Clinical Researcher of the Year involvement as sponsor, host and winner 2Chiltern expands PharmaTimes Clinical Researcher of the Year involvement as sponsor, host and winner 3GenSpera Granted New Patent for Prodrugs Activated by Prostate Specific Antigen 2
(Date:4/28/2015)... 2015 Wimbledon Health Partners, the ... electrocardiogram, echocardiogram, and NCV testing, has expanded their ... help podiatrists diagnose peripheral arterial disease (PAD). ... without the aid of vascular testing,” said ... at Wimbledon Health Partners. “Diminished peripheral pulses, atrophic ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 Once considered an ... Lights have taken the industry by storm with perfectly tailored ... use unit. , More than half of every ... KIND LED , proving the stigma is gone and LED ... overwhelming positive response from customers and their first hand experience ...
(Date:4/28/2015)... “ Gwee ” was featured on ... features the latest and coolest technology products available to ... for NewsWatch, conducted the review and shared with viewers ... As much as everyone loves their tablets, it’s annoying ... looking at them, it's even more annoying trying to ...
(Date:4/28/2015)... The Awareness Counselor team has introduced a new ... According to Awareness Counselor, there are ramifications of judging. Judging ... to an individual who self-judges. This new concept is now ... or one one one talk. , The premise of this ... that every being on earth is here for a purpose ...
(Date:4/28/2015)... Henderson, NV (PRWEB) April 28, 2015 ... University's Center for Ethics (June 27, 2014), prescription ... the world. Medical Science is becoming increasingly aware of ... on the market, such as chemotherapy drugs to treat ... bacteria that are quickly evolving to become increasingly resistant ...
Breaking Medicine News(10 mins):Health News:Podiatrists Affiliate with Wimbledon Health Partners to Diagnose Peripheral Arterial Disease 2Health News:SuperCloset Reports Surge in KIND LED Grow Light Sales, Saving Indoor Growing Enthusiasts up to 40% on their Power Usage. 2Health News:The Most Innovative iPad Case was Featured on NewsWatch Television 2Health News:What Happens When We Judge Ourselves and Others? – A New Concept Introduced 2Health News:What Happens When We Judge Ourselves and Others? – A New Concept Introduced 3Health News:Trivedi Science™ Announces the Beginning of Their Science Research to Create Highly Effective Pharmaceutical Drugs with Minimal Side Effects 2Health News:Trivedi Science™ Announces the Beginning of Their Science Research to Create Highly Effective Pharmaceutical Drugs with Minimal Side Effects 3Health News:Trivedi Science™ Announces the Beginning of Their Science Research to Create Highly Effective Pharmaceutical Drugs with Minimal Side Effects 4
... Partners is being recognized as one of the top performing California ... year. HealthCare Partners is one of only four California Physicians groups ... , ... (PRWEB) November 11, 2008 -- This is the ...
... Awareness Month--The Apo E Gene Diet--A Solution for ... Other Chronic Illnesses. ,THE APO E GENE DIET ... and Weight Loss" category of National Best Books ... E Gene Diet presents an integrative medicine solution ...
... The 2008 Frost &,Sullivan European Health Ingredient ... in recognition of its pioneering efforts in developing ... "Rather than cure, current medical treatments for ... pain," notes Frost & Sullivan,Research Analyst Kaushik Ghosh. ...
... Nov. 10 KV Pharmaceutical Company,(NYSE: KVa/KVb) announced today ... the Company will be delayed in the filing of,its ... The Company expects to,file a Form 12b-25 Notice of ... November 12, 2008., About KV Pharmaceutical Company, ...
... announced,today that the Company Chief Executive Officer, Steve ... pipeline, at the Rodman &,Renshaw,s 10th Annual Healthcare ... EST at the New York Palace Hotel, 455 ... is a private drug development Company,founded in 1996 ...
... HARRISBURG, Pa., Nov. 10 State agriculture,and health officials ... about important food safety issues made four stops in,northeastern ... Health Secretary Michael,Huff visited the area as part of ... which is a comprehensive plan to address,food safety and ...
Cached Medicine News:Health News:HealthCare Partners Rated A 'Top Performing California Physician Group' By IHA For the Fifth Straight Year 2Health News:HealthCare Partners Rated A 'Top Performing California Physician Group' By IHA For the Fifth Straight Year 3Health News:The Apo E Gene Diet--Preventing, Alzheimer's and Heart Disease, One Patient at a Time 2Health News:The Apo E Gene Diet--Preventing, Alzheimer's and Heart Disease, One Patient at a Time 3Health News:The Apo E Gene Diet--Preventing, Alzheimer's and Heart Disease, One Patient at a Time 4Health News:Frost & Sullivan Honours GELITA for Developing European Health Ingredient of the Year 2Health News:Frost & Sullivan Honours GELITA for Developing European Health Ingredient of the Year 3Health News:KV Pharmaceutical to File Form 12b-25 on November 12, 2008 2Health News:KV Pharmaceutical to File Form 12b-25 on November 12, 2008 3Health News:KV Pharmaceutical to File Form 12b-25 on November 12, 2008 4Health News:Agriculture, Health Officials Address Food Safety Concerns During Northeastern PA Tour 2
... seamless eliminating the possibility of leakage around glued ... temperature resistant gel trays meaning you do no ... added user friendliness, the Primo tanks come with ... The Primo Gel Systems are designed to be ...
... up and safe to use, the Gel XL ... and running agarose gels. The unit is compact, ... power supply eliminates a tangled mess of leads ... Designed for safety and convenience, the power supply ...
... HE 33 Mini Submarine Unit for nucleic acid analysis ... designed for very fast separations of DNA restriction fragments ... a heat-sink. Fill the base with coolant and seal. ... keeping the unit in a freezer or by immersing ...
... 2000 apparatus and ready-to-use gels are the ... of nucleic acids by submerged gel electrophoresis. ... system, offering full compatibility and optimal performance, ... SEA 2000 and a unique staining tray, ...
Medicine Products: